Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone

NCT01428089 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Ovary Syndrome
Hyperandrogenism
Normal Puberty

Interventions

DRUG: Progesterone
DRUG: Placebo

Sponsor

University of Virginia

Collaborators

[object Object]